Showing 11-20 of 7112 results for "".
- CMEhttps://practicaldermatology.com/cme/
Preparation: The Cornerstone for Effective, Efficient EHR Use
https://practicaldermatology.com/topics/practice-management/preparation-the-cornerstone-for-effective-efficient-ehr-use/21269/Physician Spotlight: Margaret E. Parsons, MD, FAAD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-margaret-e-parsons-md-faad/20605/An expert on all things creepy crawly talks shop.Physician Spotlight: Mario E. Lacouture, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-mario-e-lacouture-md/20803/Physician Spotlight: Bruce E. Strober MD, PhD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-bruce-e-strober-md-phd/23010/Physician Spotlight: Thomas E. Rohrer, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-thomas-e-rohrer-md/23337/EHRs and the Regulatory Divide
https://practicaldermatology.com/topics/practice-management/ehrs-and-the-regulatory-divide/21343/EHRs, e-prescribing, and other digital technologies are becoming increasingly indifferent to government incentives.Cracking the Codes: Telemedicine Rolls Forward
https://practicaldermatology.com/topics/practice-management/cracking-the-codes-telemedicine-rolls-forward/23226/Here’s a primer on the new online digital E/M service codes.Papa in at Valeant, J&J Acquires Neostrata, Celebrity Lip Envy
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-papa-in-at-valeant-j-j-acquires-neostrata-celebrity-lip-envy/18772/This edition of DermWireTV brings news that Joseph C. Papa has left Perrigo Company plc, a top five global over-the-counter consumer goods and pharmaceutical company, to take the helm as CEO at Valeant Pharmaceuticals. He will replace J. Micheal Pearson. Valeant also concluded its investigation arouThink Before You Sync
https://practicaldermatology.com/topics/practice-management/think-before-you-sync/20929/Is your next e-purchase digital snake oil or the real deal?